Gilead Sciences
(ETR) GIS
Gilead Sciences Financials at a Glance
Market Cap
$149.57B
Revenue (TTM)
$29.44B
Net Income (TTM)
$8.51B
EPS (TTM)
$5.95
P/E Ratio
20.25
Dividend
$2.74
Beta (Volatility)
0.02 (Low)
Dividend
$2.74
Beta (Volatility)
0.02 (Low)
Price
$119.34
Volume
286
Open
$118.68
Price
$119.34
Volume
286
Open
$118.68
Previous Close
$119.34
Daily Range
$117.98 - $120.18
52-Week Range
$82.04 - $132.00
Dividend
$2.74
Beta (Volatility)
0.02 (Low)
Price
$119.34
Volume
286
Open
$118.68
Previous Close
$119.34
Daily Range
$117.98 - $120.18
52-Week Range
$82.04 - $132.00
GIS News
GIS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gilead Sciences
Industry
Biotechnology
Sector
Health CareEmployees
17,000
CEO
Daniel P. O'Day, MBA
Website
www.gilead.comHeadquarters
Foster City, CA 94404, US
GIS Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
37%
Net Income Margin
29%
Return on Equity
39%
Return on Capital
23%
Return on Assets
14%
Earnings Yield
4.94%
Dividend Yield
0.02%
Payout Ratio
47.04%
Stock Overview
Market Cap
$149.57B
Shares Outstanding
1.24B
Volume
286
Short Interest
0.00%
Avg. Volume
1.64K
Financials (TTM)
Gross Profit
$25.52B
Operating Income
$11.82B
EBITDA
$11.82B
Operating Cash Flow
$10.02B
Capital Expenditure
$563.04M
Free Cash Flow
$9.46B
Cash & ST Invst.
$9.61B
Total Debt
$26.05B
Gilead Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.93B
+4.7%
Gross Profit
$6.88B
+14.9%
Gross Margin
86.84%
N/A
Market Cap
$149.57B
N/A
Market Cap/Employee
$8.50M
N/A
Employees
17,600
N/A
Net Income
$2.18B
+22.4%
EBITDA
$2.96B
-4.7%
Quarterly Fundamentals
Net Cash
$16.43B
-8.5%
Accounts Receivable
$4.91B
+11.2%
Inventory
$4.37B
+155.5%
Long Term Debt
$23.14B
-7.1%
Short Term Debt
$2.91B
+60.3%
Return on Assets
14.42%
N/A
Return on Invested Capital
23.30%
N/A
Free Cash Flow
$3.12B
+10.4%
Operating Cash Flow
$3.33B
+11.8%